(3R,4S)-1-苄基-4-(4-氟苯基)哌啶-3-醇 | 1423027-25-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 中文名称: (3R,4S)-1-苄基-4-(4-氟苯基)哌啶-3-醇
• 英文名称: (3R,4S)-1-benzyl-4-(4-fluorophenyl)piperidin-3-ol
• CAS: 1423027-25-1
• 化学式: C₁₈H₂₀FNO
• 分子量: 285.361
• InChiKey: NBOAJKKARIFZFK-ROUUACIJSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  21
• 可旋转键数：
  3
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  23.5
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  (3R,4S)-1-苄基-4-(4-氟苯基)哌啶-3-醇 在 10 wt% Pd(OH)2 on carbon 、 氢气 、 戴斯-马丁氧化剂 、 sodium hydroxide 作用下， 以 四氢呋喃 为溶剂， 生成 tert-butyl (4S)-4-(4-fluorophenyl)-3-oxopiperidine-1-carboxylate
  参考文献：
  名称：

  Core modification of substituted piperidines as Novel inhibitors of HDM2–p53 protein–protein interaction

  摘要：

  The discovery of 3,3-disubstituted piperidine 1 as novel p53-HDM2 inhibitors prompted us to implement subsequent SAR follow up directed towards piperidine core modifications. Conformational restrictions and further functionalization of the piperidine core were investigated as a strategy to gain additional interactions with HDM2. Substitutions at positions 4, 5 and 6 of the piperidine ring were explored. Although some substitutions were tolerated, no significant improvement in potency was observed compared to 1. Incorporation of an allyl side chain at position 2 provided a drastic improvement in binding potency. (C) 2014 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2014.02.055
• 作为产物：
  描述：

  (4S,5R)-4-(4-氟苯基)-5-羟基哌啶-2-酮 在 dimethyl sulfide borane 、 sodium carbonate 作用下， 以 四氢呋喃 、 二氯甲烷 、 水 为溶剂， 反应 14.0h， 生成 (3R,4S)-1-苄基-4-(4-氟苯基)哌啶-3-醇
  参考文献：
  名称：

  通过两个3位取代的环氧酯的立体中心HKR 光学纯净的γ-丁内酯和环氧酯：（-）-帕罗西汀，Ro 67-8867和（+）-依加多醇的正式合成†

  摘要：

  外消旋的HKR抗-或顺式-3-取代的环氧酯通过将Co（催化III salen络合物）提供到相应的对映体富集3,4-二取代γ丁内酯和3-取代的环氧酯随时获得。该策略已成功用于生物学活性的3,4-二取代哌啶衍生物（-）-帕罗西汀和Ro 67-8867以及天然产物（+）-依加醇化物的形式合成中。

  DOI：

  10.1039/c3ob27321k

文献信息

• Optically pure γ-butyrolactones and epoxy esters via two stereocentered HKR of 3-substituted epoxy esters: a formal synthesis of (−)-paroxetine, Ro 67-8867 and (+)-eldanolide
  作者：Dattatray A. Devalankar、Pratibha U. Karabal、Arumugam Sudalai

  DOI：10.1039/c3ob27321k

  日期：——

  racemic anti- or syn-3-substituted epoxy esters catalyzed by a Co(III)salen complex provides ready access to the corresponding enantioenriched 3,4-disubstituted γ-butyrolactones and 3-substituted epoxy esters. This strategy has been successfully employed in the formal synthesis of biologically active 3,4-disubstituted piperidine derivatives, (−)-paroxetine and Ro 67-8867 and a natural product, (+)-eldanolide

  外消旋的HKR抗-或顺式-3-取代的环氧酯通过将Co（催化III salen络合物）提供到相应的对映体富集3,4-二取代γ丁内酯和3-取代的环氧酯随时获得。该策略已成功用于生物学活性的3,4-二取代哌啶衍生物（-）-帕罗西汀和Ro 67-8867以及天然产物（+）-依加醇化物的形式合成中。
• Core modification of substituted piperidines as Novel inhibitors of HDM2–p53 protein–protein interaction
  作者：Weidong Pan、Brian R. Lahue、Yao Ma、Latha G. Nair、Gerald W. Shipps、Yaolin Wang、Ronald Doll、Stéphane L. Bogen

  DOI：10.1016/j.bmcl.2014.02.055

  日期：2014.4

  The discovery of 3,3-disubstituted piperidine 1 as novel p53-HDM2 inhibitors prompted us to implement subsequent SAR follow up directed towards piperidine core modifications. Conformational restrictions and further functionalization of the piperidine core were investigated as a strategy to gain additional interactions with HDM2. Substitutions at positions 4, 5 and 6 of the piperidine ring were explored. Although some substitutions were tolerated, no significant improvement in potency was observed compared to 1. Incorporation of an allyl side chain at position 2 provided a drastic improvement in binding potency. (C) 2014 Elsevier Ltd. All rights reserved.